Notice of first launch, interruption or termination of supply of a human drug
 Date ▲HolderCodeDrugDate fromSubject
 25.2.2022Teva Czech Industries s.r.o. (TEV-CZ-2)10184EQUORAL 50 mg (cps mol 50x50 mg (blis.Al/Al))28.2.2022R
 25.2.2022Teva B.V. (TEV-NL-4)8472CAprepitant Teva 80 mg a Aprepitant Teva 125 mg (cps dur 1x125 mg+2x80 mg (blis.Al/OPA/Al/PVC))1.6.2022Z
 25.2.2022ratiopharm GmbH (RAT)37703Moxonidin-ratiopharm 0,3 mg (tbl flm 100x0,3 mg (blis.PVC/PVDC/Al))8.3.2022R
 25.2.2022Teva B.V. (TEV-NL-4)7563AIsotretinoin Actavis 20 mg (cps mol 30x20 mg (blis.PVC/PVDC/Al))1.5.2022R
 24.2.2022sanofi-aventis groupe (SOI-1)61178Colimycine (plv ino 50x1 MIU (liek.inj.skl.))10.4.2022Z
 24.2.2022sanofi-aventis groupe (SOI-1)64875Solian 100 mg (tbl 30x100 mg (blis.PVC/Al))20.3.2022Z
 24.2.2022Bayer, spol. s r.o. (BAY-SK-2)96230ASPIRIN C (tbl eff 20x400 mg/240 mg (strip papier/PE/Al/Surlyn))25.2.2022R
 24.2.2022Viatris Limited (VIM)9178BVorikonazol Mylan 200 mg (plv ifo 1x200 mg (liek.inj.skl.))28.2.2022Z
 24.2.2022Zentiva, k.s. (ZNT-1)13556Agen 5 (tbl 30x5 mg (blis. PVC/PVDC/Al))24.2.2022R
 24.2.2022Zentiva, k.s. (ZNT-1)3037BTorvacard Novum 10 mg (tbl flm 30x10 mg (blis.OPA/Al/PVC/Al))10.3.2022R
 24.2.2022Zentiva, k.s. (ZNT-1)3061BTorvacard Novum 40 mg (tbl flm 30x40 mg (blis.OPA/Al/PVC/Al))31.3.2022R
 24.2.2022Zentiva, k.s. (ZNT-1)3065BTorvacard Novum 40 mg (tbl flm 90x40 mg (blis.OPA/Al/PVC/Al))31.3.2022R
 24.2.2022Zentiva, k.s. (ZNT-1)3077BTorvacard Novum 80 mg (tbl flm 90x80 mg (blis.OPA/Al/PVC/Al))24.2.2022R
 24.2.2022B.Braun Melsungen AG (BME)41821Lipoplus 20 % (emu inf 10x500 ml (fľ.skl.))23.2.2022O
 23.2.2022Recordati Industria Chimica e Farmaceutica S.p.A. (REC-1)42283Eligard 22,5 mg (plv iol 1x22,5 mg+1x solv. (striek.inj.napl."A"s PP viečkom+striek.inj.napl."B"+ihla))23.2.2022R

Subject means:
U-Placement of medicine to Slovakian market, R-Discontinuation of medicine supply to Slovakian market,
O-Resumption of medicine supply to Slovakian market, Z-Cancelation of medicine supply to Slovakian market


Date from
From
To